Research study Program year 2022 Source: CMS Open Payments

A Phase 3, Randomized, Double-Blind Study of COSELA or Placebo in Patients Receiving First- or Second-Line Gemcitabine and Carboplatin Chemotherapy for Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (PRESERVE-2)

Research payments

$10,805,321

2,033 payments

Through program year 2022, $10,805,321 in research payments was reported against A Phase 3, Randomized, Double-Blind Study of COSELA or Placebo in Patients Receiving First- or Second-Line Gemcitabine and Carboplatin Chemotherapy for Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (PRESERVE-2), across 2,033 payments, paid by G1 Therapeutics, Inc..

Paid by
G1 Therapeutics, Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

1 row
Year Kind Amount Payments
2022 Research $10,805,321 2,033

Breakdown

Who paid Research payments · program year 2022
  1. G1 Therapeutics, Inc. $10,805,321 2,033 payments
Who received the money Research payments · program year 2022
  1. Sarah Cannon Research Institute, LLC Organisation paid for research $1,032,995 173 payments
  2. Millennium Research And Clinical Development LLC Organisation paid for research $911,941 39 payments
  3. US Oncology Research LLC Organisation paid for research $837,192 330 payments
  4. Beverly Hills Oncology Medical Group, Inc Organisation paid for research $802,812 66 payments
  5. Ohsu Hospital And Clinics Teaching hospital · OR $648,640 26 payments
  6. Inova Loudoun Hospital Center Teaching hospital · VA $530,481 30 payments
  7. Sarah Cannon Research Institute LLC Organisation paid for research $484,339 274 payments
  8. Keck Hospital Of Usc Teaching hospital · CA $448,934 13 payments
  9. Los Angeles Hematology Oncology Medical Group Organisation paid for research $402,890 28 payments
  10. Board Of Regents Of The University Of Oklahoma Health Sciences Center Organisation paid for research $402,427 18 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record